These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 740997)

  • 1. [Exploration of the route of complement activation in idiopathic membranoproliferative glomerulonephritis and lupic nephropathy].
    Gutiérrez Millet V; Prieto C; Ortuño MT; Usera G; Jarillo MD; Ruilope LM; Rodicio JL
    Rev Clin Esp; 1978 Nov; 151(3):223-8. PubMed ID: 740997
    [No Abstract]   [Full Text] [Related]  

  • 2. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in clinical methods of complement system analysis and data interpretation].
    Inai S
    Nihon Rinsho; 1988 Sep; 46(9):2046-53. PubMed ID: 3149350
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of B-lymphocytes with receptors to C3 component of complement in patients with glomerulonephritis and systemic lupus erythematosus].
    Gordovskaia NB; Bulanova TD; Traianova TG
    Ter Arkh; 1977; 49(7):45-50. PubMed ID: 331546
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serial studies of serum immune complexes and complements in patients with glomerulonephritis].
    Nakayama S; Koide H; Ohno J
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):163-9. PubMed ID: 6611432
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complement activation of alternative pathway in renal diseases and systemic lupus erythematosus (author's transl)].
    Nakayama S
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):447-61. PubMed ID: 529617
    [No Abstract]   [Full Text] [Related]  

  • 8. [Process of complement activation in systemic lupus erythematosus and acute nephritis].
    Otani I
    Nihon Jinzo Gakkai Shi; 1976 Sep; 18(9):547-63. PubMed ID: 1034132
    [No Abstract]   [Full Text] [Related]  

  • 9. The kidney in systemic lupus erythematosus.
    Cameron JS; Turner DR; Vosnides G; Leibowitz S; Lessof MH; Ogg CS; Chantler C; Brown CB
    Perspect Nephrol Hypertens; 1977; 6():41-81. PubMed ID: 320552
    [No Abstract]   [Full Text] [Related]  

  • 10. Membranous glomerulopathy in systemic lupus erythematosus.
    Gonzalez-Dettoni H; Tron F
    Adv Nephrol Necker Hosp; 1985; 14():347-64. PubMed ID: 3919538
    [No Abstract]   [Full Text] [Related]  

  • 11. [Whole serum complement in kidney diseases and systemic lupus erythematosus].
    Stein G; Stelzner A; Tanner E
    Z Gesamte Inn Med; 1973 Aug; 28(16):469-76. PubMed ID: 4129087
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activity of the complement system in nephropathies of childhood].
    Zelazko ME; Feldman G
    Medicina (B Aires); 1977; 37(3):205-14. PubMed ID: 895495
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anomalies of the complement system in human nephropathies].
    Kourilsky O
    Cah Med; 1973 Jun; 14(6):389-97. PubMed ID: 4203255
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of hemolytic complement activity via classical pathway].
    Takemura S; Kondo M
    Nihon Rinsho; 1990 Feb; 48 Suppl():634-6. PubMed ID: 2355588
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis.
    Soothill JF
    Clin Exp Immunol; 1967 Jan; 2(1):83-92. PubMed ID: 4166187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease.
    Gilliam JN; Cheatum DE; Hurd ER; Stastny P; Ziff M
    J Clin Invest; 1974 May; 53(5):1434-40. PubMed ID: 4596508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complement activation at low temperature. I. The profile of complement component of patients' sera].
    Yukiyama Y; Yoshida K; Hirose S
    Arerugi; 1984 May; 33(5):275-81. PubMed ID: 6477140
    [No Abstract]   [Full Text] [Related]  

  • 18. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activated complement in systemic lupus erythematosus].
    Porcel JM; Ordi J
    Med Clin (Barc); 1991 Feb; 96(4):135-7. PubMed ID: 2023487
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
    Daha MR; Van Es LA
    Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.